Squarepoint’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-319,226
Closed -$12.6M 3192
2025
Q1
$12.6M Buy
319,226
+108,431
+51% +$4.28M 0.02% 485
2024
Q4
$6.34M Buy
210,795
+162,082
+333% +$4.88M 0.01% 678
2024
Q3
$1.14M Sell
48,713
-2,998
-6% -$70.1K ﹤0.01% 1380
2024
Q2
$920K Sell
51,711
-9,573
-16% -$170K ﹤0.01% 1411
2024
Q1
$932K Sell
61,284
-264,540
-81% -$4.02M ﹤0.01% 1391
2023
Q4
$5.57M Buy
325,824
+254,749
+358% +$4.35M 0.01% 637
2023
Q3
$594K Buy
+71,075
New +$594K ﹤0.01% 1537
2023
Q2
Sell
-67,179
Closed -$1.01M 2832
2023
Q1
$1.01M Sell
67,179
-15,954
-19% -$240K ﹤0.01% 1158
2022
Q4
$983K Sell
83,133
-33,005
-28% -$390K ﹤0.01% 1107
2022
Q3
$688K Buy
+116,138
New +$688K ﹤0.01% 1261
2022
Q1
Sell
-13,279
Closed -$252K 2812
2021
Q4
$252K Buy
+13,279
New +$252K ﹤0.01% 1958
2020
Q2
Sell
-73,590
Closed -$724K 2436
2020
Q1
$724K Buy
+73,590
New +$724K 0.02% 863
2019
Q3
Sell
-35,696
Closed -$309K 2541
2019
Q2
$309K Buy
35,696
+9,621
+37% +$83.3K ﹤0.01% 1869
2019
Q1
$210K Buy
+26,075
New +$210K ﹤0.01% 1878
2018
Q3
Sell
-14,200
Closed -$187K 2213
2018
Q2
$187K Sell
14,200
-19
-0.1% -$250 ﹤0.01% 1556
2018
Q1
$202K Sell
14,219
-3,755
-21% -$53.3K ﹤0.01% 1487
2017
Q4
$147K Buy
+17,974
New +$147K ﹤0.01% 1868
2017
Q1
Sell
-39,605
Closed -$184K 1889
2016
Q4
$184K Buy
+39,605
New +$184K 0.01% 1471
2016
Q1
Sell
-23,500
Closed -$280K 1442
2015
Q4
$280K Buy
+23,500
New +$280K 0.03% 828